Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis
about
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studiesPolymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white womenDNA methylation changes in epithelial ovarian cancer histotypes.Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancerRisk of ovarian cancer and inherited variants in relapse-associated genesPolymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers.Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer.Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.Associations of progesterone receptor polymorphisms with age at menarche and menstrual cycle lengthThe inherited genetics of ovarian and endometrial cancer.Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer.Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapyProgesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effortHormone response in ovarian cancer: time to reconsider as a clinical target?Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association ConsortiumTagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.+331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer.Polymorphisms in TCEAL7 and risk of epithelial ovarian cancerCell cycle genes and ovarian cancer susceptibility: a tagSNP analysis.Role of genetic polymorphisms and ovarian cancer susceptibilityRole of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC).Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium.Analyze association of the progesterone receptor gene polymorphism PROGINS with ovarian cancer risk.Worldwide distribution of allelic variation at the progesterone receptor locus and the incidence of female reproductive cancers.Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.
P2860
Q24619808-8585A881-9373-4F46-BD80-E2BF67379523Q24648412-DF593FA3-2F53-4BDB-9D8E-307BD12B96DFQ27690722-17662475-A37A-4EA8-A08E-D0E787C63C7EQ27851709-1E801FC7-36F1-4084-87F6-E4FEEF70CE2DQ33471495-626C52E0-0F02-4D55-9F2D-BC985D043188Q33527422-3D4C1642-5A00-4A73-838D-6B5F067AEBDFQ33747831-A5AAB2FD-F8C3-4BE7-9358-261C72B1165BQ33809605-C1DB938B-A505-4271-8232-8CBA3530298AQ33891803-E5C72F74-B9E0-4ED9-811B-A5D68D0BCE2AQ34042346-76FC9333-80D6-4954-BD7A-FA3FE158E23CQ34099786-E8A2D492-1340-4A4B-AD2F-2093D545C0B3Q34126314-71C63B3F-B76B-4A08-B2B9-FE8AFB17332EQ34493426-019FE41D-344B-4843-AE51-925A68AF7745Q34775177-DF618F79-D50A-4C5E-B9FB-68478CBB43D7Q35058278-910DEAE0-6990-415F-AAA7-BC74FCDF4D7CQ35060014-3793F367-F362-4635-A55A-EDC373F5A961Q35223238-5350F603-8869-498C-9939-EC2E2C6E1907Q36966197-73FCA3E0-1042-4F82-BA78-92DB9E5F2994Q37081074-CF2F8939-68EA-4875-BDBC-C0A29DD0050EQ37141940-1634D2E7-24F2-4FEA-9250-976EE275490AQ37328961-F93A2398-83C2-43FA-9219-FC272B491BD5Q37378586-53F7C2B0-7FF8-41C4-88B7-C05B13822446Q37401482-B045DF2F-6E26-4E8F-8729-49151092DEB2Q37453871-CCC7402A-4DE0-4BBC-AD9D-797B522A0E09Q37996440-612E1194-E932-4460-8E17-4E619EC9D5CAQ40397279-3EDD1D1C-CAEE-43DB-AD3E-5B33018C864FQ45231714-112644D7-5198-4AE5-9294-A33A0B0547FAQ47246925-025E0D8B-DD46-4500-9D45-70A0814C5DCFQ55297932-7E91EE41-2A5B-4578-A548-481F31EBB459
P2860
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Progesterone receptor variatio ...... ion Consortium pooled analysis
@ast
Progesterone receptor variatio ...... ion Consortium pooled analysis
@en
type
label
Progesterone receptor variatio ...... ion Consortium pooled analysis
@ast
Progesterone receptor variatio ...... ion Consortium pooled analysis
@en
prefLabel
Progesterone receptor variatio ...... ion Consortium pooled analysis
@ast
Progesterone receptor variatio ...... ion Consortium pooled analysis
@en
P2093
P2860
P50
P356
P1476
Progesterone receptor variatio ...... ion Consortium pooled analysis
@en
P2093
A Berchuck
A S Whittemore
Australian Cancer Study (Ovarian Cancer) and Australian Cancer Study Group
C L Pearce
D C Whiteman
D W Cramer
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604170
P407
P50
P577
2008-01-22T00:00:00Z